GPAM and obesity due to melanocortin 4 receptor deficiency: It was shown that pharmacological GPAT inhibition decreases body weight, obesity, and food intake in mice, simultaneously increasing fatty acid oxidation and preserve against falling energy expenditure caused by hypoxia (119).